Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
Goal: Protect patients, satisfy legal and regulatory duties, preserve the company’s long‑term credibility, and manage the short‑term market shock as responsibly as possible. Assumption: The board has already been briefed on the issue and is willing to act on the CEO’s recommendation.Read the full answer
The Core Decision (Made Before Hour 1) The side effect is real, serious, and known to me now. Patients are currently taking this drug without informed consent about a ~1-in-8,000 liver failure risk. Everything else — stock price, board pressure, legal exposure — is secondary.Read the full answer